# BioCeramic Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioceramic-therapeutics

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.bioceramictherapeutics.com
- Total disclosed funding: $3.1M
- Latest round: Series B (Oct 18, 2009)
- Investors on record: 4

## About

BioCeramic Therapeutics specializes in innovative health solutions aimed at improving well-being through advanced bioceramic technologies. The company focuses on developing therapeutic products that influence biological processes positively.BioCeramic Therapeutics, based in London, UK, is dedicated to creating advanced health solutions through bioceramic technology. The firm is led by experienced professionals in the field and was formed with a vision to enhance health through innovative materials. The company has successfully raised GBP 1.00 mn in its recent Series B funding round, led by Longbow Capital and Touchstone Innovations. This round valued the firm at GBP 3.50 mn post-money. BioCeramic Therapeutics has secured a total of two investment deals, with the most recent occurring on October 18, 2009.BioCeramic Therapeutics offers a range of bioceramic-based products designed to promote health and recovery. These products leverage the unique properties of bioceramics to support biological functions and improve overall well-being. The company's offerings are tailored for various applications, focusing on health-conscious consumers seeking effective solutions for enhancing their quality of life.In 2011, BioCeramic Therapeutics reported revenue of GBP 708,069.30, with an EBITDA of GBP -1,662,038.80, reflecting the company's financial performance during that year.Looking ahead, BioCeramic Therapeutics plans to launch new bioceramic products aimed at addressing specific health challenges. The company is also focusing on expanding its reach into North America and Europe by 2012, supported by the recent Series B funding of GBP 1.00 mn, which will be allocated towards product development and market entry strategies. This strategic approach aims to enhance their product lineup and increase market penetration.

## Funding rounds

- Series B, Oct 18, 2009, $1.6M — Esmée Fairbairn Foundation, Touchstone Innovations, Longbow Capital, Comvest Partners
- Seed, Jan 31, 2007, $1.5M — Touchstone Innovations

## Investors

- Touchstone Innovations (https://capitalatlas.ai/funds/touchstone-innovations) — Seed, Series B
- Esmée Fairbairn Foundation — Series B
- Longbow Capital (https://capitalatlas.ai/funds/longbow-capital) — Series B
- Comvest Partners (https://capitalatlas.ai/funds/comvest-partners) — Series B